Patent classifications
C07K14/395
INCREASED ETHANOL PRODUCTION BY OVEREXPRESSION OF JID1 IN YEAST
Described are compositions and methods relating to modified yeast that over-expresses the J-protein, JID1. The yeast produces an increased amount of ethanol compared to otherwise identical parental cells. Such yeast is particularly useful for large-scale ethanol production from starch substrates.
ENGINEERED YEAST FOR NONMAGNETIC FINES RECOVERY
The disclosure provides a magnetic reagent comprised of a recombinant yeast cell having the following genetic modifications: impairment of the CCC1 gene; addition of at least one copy of a human ferritin gene complex; addition of at least one copy of a TCO89 gene; and addition of at least one copy of a mineral- or metal ion-adsorbing target peptide, wherein the magnetic susceptibility or mass magnetization of said magnetic reagent is greater than it would be for a native yeast.
Electrically conductive protein nanofibers and biofilms
Methods of making engineered protein-based materials, nanofibers, and biofilms from bacterial amyloid-based structures that are capable of mediating long-range electron transport are provided.
Electrically conductive protein nanofibers and biofilms
Methods of making engineered protein-based materials, nanofibers, and biofilms from bacterial amyloid-based structures that are capable of mediating long-range electron transport are provided.
Mutant yeast strain with decreased glycerol production
The disclosure relates to the use of a mutant SSK1 gene encoding a truncated ssk1 protein for the construction of a mutant yeast strain with decreased glycerol production, when compared to the wild-type strain. It relates further to the use of such strains for high-yield bioethanol production, especially in high osmotic media, or on cellulosic hydrolysates, where normal yeast strains do produce a significant amount of glycerol.
Mutant yeast strain with decreased glycerol production
The disclosure relates to the use of a mutant SSK1 gene encoding a truncated ssk1 protein for the construction of a mutant yeast strain with decreased glycerol production, when compared to the wild-type strain. It relates further to the use of such strains for high-yield bioethanol production, especially in high osmotic media, or on cellulosic hydrolysates, where normal yeast strains do produce a significant amount of glycerol.
RECOMBINANT YEAST HOST CELL EXPRESSING AN HYDROLASE
The present disclosure concerns a recombinant yeast host cell exhibiting higher stability and, in some embodiments, higher fermentation performance. The recombinant yeast host cell stability has a limited ability to express an hydrolase during its propagation phase. In return, this limits the cleavage of a yeast cellular component during or after propagation which may be detrimental to the stability and/or fermentation performances. The recombinant yeast host cell expresses a heterologous hydrolase under the control of a heterologous promoter (for limiting the expression of the heterologous hydrolase during propagation and favoring the expression of the heterologous hydrolase during fermentation).
Causative genes conferring acetic acid tolerance in yeast
The present invention relates to genes conferring acetic acid tolerance in yeast. More specifically, the invention relates to the use of DOT5, preferably in combination with CUP2 and/or HAA1 to obtain acid tolerance in yeast. Even more preferably, the invention relates to specific alleles of said genes, and to yeast strains comprising said specific alleles.
Causative genes conferring acetic acid tolerance in yeast
The present invention relates to genes conferring acetic acid tolerance in yeast. More specifically, the invention relates to the use of DOT5, preferably in combination with CUP2 and/or HAA1 to obtain acid tolerance in yeast. Even more preferably, the invention relates to specific alleles of said genes, and to yeast strains comprising said specific alleles.
GENETIC FACTOR TO INCREASE EXPRESSION OF RECOMBINANT PROTEINS
Materials and methods that involve overexpression of a transcriptional activator such as retrograde regulation protein 1 (Rtg1) for increasing expression of one or more polypeptides.